User profiles for "author:Tony El Jabbour"

Tony El Jabbour

Memorial Sloan Kettering Cancer Center
Verified email at montefiore.org
Cited by 279

[HTML][HTML] Update on hepatocellular carcinoma: Pathologists' review

T El Jabbour, SM Lagana, H Lee - World journal of …, 2019 - ncbi.nlm.nih.gov
Histopathologic diversity and several distinct histologic subtypes of hepatocellular
carcinoma (HCC) are well-recognized. Recent advances in molecular pathology and …

Challenges in diagnosing and reporting cholangiocarcinoma

T El Jabbour, A Molnar… - Surgical Pathology …, 2023 - surgpath.theclinics.com
Intrahepatic cholangiocarcinoma is a challenge to the practicing surgical pathologist for
several reasons. It is rare in many parts of the world, and thus practical exposure may be …

[HTML][HTML] Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine

A Molnar, H Monroe, H Basri Aydin, ME Arslan… - Current …, 2023 - mdpi.com
Immunotherapy has remained at the vanguard of promising cancer therapeutic regimens
due to its exceptionally high specificity for tumor cells and potential for significantly improved …

PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and-proficient colorectal cancer: the foundation study using the SP142 …

T El Jabbour, JS Ross, CE Sheehan… - Journal of Clinical …, 2018 - jcp.bmj.com
Aims Routine application of PD-L1 immunohistochemistry (IHC) in colorectal cancer (CRC)
is limited due to lack of standardized scoring criteria, antibody clones, and intratumoral …

General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study

H Lee, T El Jabbour, S Ainechi, LM Gay, JA Elvin… - Human pathology, 2017 - Elsevier
Hepatoblastoma (HBL) is a hepatic malignancy of infants and young children, which is often
cured by combinations of surgery and chemotherapy. Management of refractory and …

Features That Aid Identification of Autoimmune Gastritis in a Background of Active Helicobacter pylori Infection

J Choudhuri, S Hall… - … of Pathology & …, 2021 - meridian.allenpress.com
Context.—Helicobacter pylori–associated and autoimmune gastritis may coexist in a subset
of patients who require treatment for both disorders. Objective.—To delineate findings that …

[HTML][HTML] Features of endoscopic procedure site reaction associated with a recently approved submucosal lifting agent

CA Castrodad-Rodríguez, NC Panarelli, AJ Gersten… - Modern Pathology, 2020 - Elsevier
Endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and
endoscopic submucosal dissection (ESD), are frequently aided by injection of submucosal …

[HTML][HTML] Histologic lesions of Porto-Sinusoidal Vascular Disease following phlebotomy in hemochromatosis

T El Jabbour, KE McHugh, DT Patil, C Zuo… - Gastroenterology …, 2020 - ncbi.nlm.nih.gov
Background Phlebotomy induces regression of liver fibrosis in genetic hemochromatosis.
We assessed the histologic changes in pre-phlebotomy and post-phlebotomy liver biopsies …

[HTML][HTML] Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate

M Aldyab, T El Jabbour, M Parilla… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Several benign conditions such as chronic pancreatitis, autoimmune pancreatitis, and
paraduodenal pancreatitis can present as mass lesions and may mimic pancreatic ductal …

[HTML][HTML] Retrospective analysis of discordant results between histology and other clinical diagnostic tests on helicobacter pylori infection

X Qi, K Kuan, T El Jabbour, Y Lo, Q Liu… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND A reliable test is essential for diagnosing Helicobacter pylori (H. pylori)
infection, and crucial for managing H. pylori-related diseases. Serving as an excellent …